Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949. (Q36088918)

12 August 2017

Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949. (English)

1 reference

12 August 2017

1 reference

2

Catherine M Tangen

1 reference

12 August 2017

Primo N Lara

1

1 reference

12 August 2017

Sarah J Conlon

3

1 reference

12 August 2017

Robert C Flanigan

4

1 reference

12 August 2017

E David Crawford

5

1 reference

12 August 2017

Southwest Oncology Group Trial S8949

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

18 December 2008

1 reference

12 August 2017

1 reference

12 August 2017

181

1 reference

12 August 2017

2

1 reference

12 August 2017

512-6; discussion 516-7

1 reference

Renal cell carcinoma: current status and emerging therapies

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394523

Prognostic value of thrombocytosis in renal cell carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394523

Biochemical and molecular markers in renal cell carcinoma: an update and future prospects.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394523

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394523

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394523

Prognostic factors in renal carcinoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394523

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394523

Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394523

Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394523

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394523

Validation of the ucla integrated staging system for patients with renal cell carcinoma

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3394523

Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19100570

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JURO.2008.10.021

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

19100570

1 reference